Show simple item record

Authordc.contributor.authorAlarcón, Luis 
Authordc.contributor.authorRau, Matías 
Authordc.contributor.authorPrat Martorell, Hernán 
Authordc.contributor.authorFernández, René 
Authordc.contributor.authorCarmona, Jaime 
Authordc.contributor.authorZhindon, Juan P. 
Authordc.contributor.authorGonzález, Javiera 
Authordc.contributor.authorMassardo, Teresa 
Admission datedc.date.accessioned2019-03-18T12:03:54Z
Available datedc.date.available2019-03-18T12:03:54Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationRevista Medica de Chile, Volumen 146, Issue 8, 2018, Pages 831-839
Identifierdc.identifier.issn07176163
Identifierdc.identifier.issn00349887
Identifierdc.identifier.other10.4067/s0034-98872018000800831
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/167706
Abstractdc.description.abstract© 2018, Sociedad Medica de Santiago. All rights reserved. Background: Dipyridamole (DIP) is the most commonly employed pharmacological stressor for myocardial perfusion tomography (SPECT) in patients unable to reach an adequate work load. Aim: To assess the predictive capacity of DIP SPECT on survival. Material and Methods: We included 985 adults aged 66 ±11 years (45% women) with rest and DIP-SPECT. The main indications for the procedure were coronary artery disease (CAD) screening in 66% and known CAD in 33%. Participants were followed up for a median of 65 months (interquartile range 54 to 86 months). During the follow up, 261 deaths were recorded and 98% had a specified cause in their death certificate. Results: Myocardial SPECT was abnormal in 44% of participants. Transient ischemic defects were observed in 34%, fixed defects concordant with infarction in 27% and post-stress systolic dysfunction in 23%. Twenty five percent of deaths were attributable to cardiac or ischemic cause a
Lenguagedc.language.isoen
Publisherdc.publisherSociedad Medica de Santiago
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista Medica de Chile
Keywordsdc.subjectDipyridamole
Keywordsdc.subjectEmission-computed
Keywordsdc.subjectPrognosis
Keywordsdc.subjectSingle-photon
Keywordsdc.subjectTomography
Títulodc.titlePredictive value of dipyridamole myocardial perfusion tomography on survival Estratificación de riesgo de muerte a mediano plazo de pacientes evaluados por enfermedad coronaria con SPECT de perfusión miocárdica bajo efecto de dipiridamol
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile